For over 60 years, HOYA Vision Care has been a passionate and global leader in optical technology innovation. As a manufacturer of high quality, high performing eyeglass lenses, HOYA continuously aims to bring the best possible vision care solutions to Eye Care Professionals and their patients around the world. In 2018, the company proudly rolled out its innovative and evidence-based myopia management solution with its research partner, the Centre for Myopia Research at The Hong Kong Polytechnic University4,5.

“Through intensive research on myopia that is aligned with the aggressive development of our product offerings, HOYA aims to be at the forefront of myopia management as we remain steadfast in our commitment to producing innovative eye care solutions that aim to deliver optimal results for all our patients,” shares HOYA Vision Care CEO Alexandre Montague.

image 14 HOYA Vision Care Renews Its Commitment to Providing Myopia Solutions

(From left to right) Oxana Pastushenko (Chief Marketing Officer, HOYA Vision Care); Alexandre Montague (Chief Executive Officer, HOYA Vision Care); Ananda Wibowo (Managing Director); and Eleonor Gonzales (Commercial Director, HOYA Lens Philippines Inc.) during the media roundtable.

Combating Myopia in the Philippines

Myopia, or nearsightedness, is a vision condition wherein individuals can see objects clearly up close but may appear blurred further away. Currently, global data have shown that over 22.9% of the world population have myopia with 2.7% having high myopia. It is predicted to increase to 49.8% and 9.8% of which is high myopia by 20504..

Philippine Eye Research Institute study has shown that Filipino children are most likely to be affected by visual impairment, which doubles when they reach adolescence[8]. As students massively transitioned to the digital platform brought about by the pandemic, research has shown that children who use screens for greater than three hours per day are almost four times more likely to be myopic compared to those spending one hour on screens per day1. 

While myopia is irreversible and incurable which can lead to an increased risk of having vision-threatening conditions such as cataracts, glaucoma, and retinal detachment if it is left unaddressed,[9] the condition can be managed through early intervention and regular consultations with eye care practitioners who are equipped to provide professional advice in finding the right myopia management options. Moreover, the Philippine government constantly pushes for regular and comprehensive eye screening among kindergarten students through the National Vision Screening Program (NVSP) which was mandated in 2019.

These efforts are aligned with HOYA’s commitment to constantly provide innovative solutions to cater to the ever-changing needs of its patients. During the discussion, Oxana Pastushenko talks about HOYA’s award-winning product[10],[11] MiYOSMART, which are spectacle lenses that correct the visual defect using the revolutionary D.I.M.S. (Defocus Incorporated Multiple Segments) technology, proven to slow down myopia progression by 60%12,13

“While we cannot control factors that may lead to rapid myopia progression in children, we are keen to ensure that innovative, non-invasive myopia management options are accessible to parents as MiYOSMART becomes available in the Philippines. Children’s vision is worth protecting, alongside the upcoming launch of MiYOSMART, HOYA will also be initiating an awareness campaign aimed at parents, educating them on the risks of myopia towards long-term eye health and the impact of poor eyesight on academic performance. It is important for parents to monitor their children’s eyesight by having regular eye checks so as not to deprive children from the right to see clearly. Let us act now, and give them more opportunity tomorrow”. concludes Montague.

To know more about HOYA Vision, you may visit their website at https://www.hoyavision.com/ph/


[1] Harrington, S., Stack, J. & O’Dwyer, V. Risk factors associated with myopia in schoolchildren in Ireland | British Journal of Ophthalmology (2019)

[2] Phil Population: Philippine Population 2023 Worldometer

[3] Ma, X., Z. Zhou, H. Yi, X. Pang, Y. Shi, Q. Chen, M. Meltzer, S. le Cessie, M. He, S. Rozelle, Y. Liu, and N. Congdon. 2014. “Effect of Providing Free Glasses on Children’s Educational Outcomes in China: Cluster-randomized controlled trial”. BMJ 349:g5740.

[4] Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042.

[5] Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology Published Online First: 17 March 2021. doi: 10.1136/bjophthalmol-2020-317664

[6] Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. Doi: 10.1136/bjophthalmol-2018-313739

7Myopia control in children wearing DIMS spectacle lens: 6 years results (Abstract). Invest Ophthalmol Vis Sci. 2022;63(7):4247. Available from: https:// iovs.arvojournals.org/article.aspx?articleid=2781769 (Last accessed 04/01/2023)

[7]8

[8]8 https://www.upm.edu.ph/node/4051 Highlight on visual impairment among Filipino children

[9]9 Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042.

10Winners of the exhibition’s grand prix. Inventions Geneva. N.D. Available from: https://inventions-geneva.ch/en/winners/ (Last accessed 01/02/2023)

11Winners 2020. Silmo Paris. 2020. https://en.silmoparis.com/SILMO- d-OR/SILMO-d-Or-Awards/2020-Winners# (Last accessed 12/01/2023)

[10]12Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. Doi: 10.1136/bjophthalmol-2018-313739

[11]13 Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology Published Online First: 17 March 2021. doi: 10.1136/bjophthalmol-2020-317664